Pennsylvania 2023-2024 Regular Session

Pennsylvania Senate Bill SB253

Introduced
1/31/23  

Caption

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

Impact

The bill's implementation has significant implications for state laws, as it promotes a shift towards treatment over incarceration for offenders suffering from substance use disorders. By mandating assessments for nonnarcotic medication-assisted treatment, the bill not only aims to reduce relapse rates but also attempts to alleviate some pressures on the judicial system by addressing the root cause of criminal behaviors linked to substance abuse. Moreover, the introduction of eligible providers who are tasked with conducting assessments and administering treatment marks a pivotal shift in how substance dependencies are managed within the context of the legal system.

Summary

Senate Bill 253, introduced in Pennsylvania, establishes the Nonnarcotic Medication Substance Use Disorder Treatment Program aimed at providing a structured approach to addressing substance use disorders among offenders. The bill amends several titles in the Pennsylvania Consolidated Statutes, specifically focusing on enhancing the treatment options available within the criminal justice system. It outlines the responsibilities of the Department of Drug and Alcohol Programs and creates a framework for grant funding to support these initiatives. The program is designed to facilitate individualized treatment for offenders, particularly those imposed with various sentencing options such as confinement or probation.

Sentiment

Overall, the sentiment surrounding SB253 appears to be positive among treatment advocates and some legislators who emphasize the need for a more compassionate approach to dealing with individuals involved in the criminal justice system due to substance-related issues. Supporters argue that focusing on rehabilitation through medical treatment rather than punitive measures will yield better long-term outcomes for both individuals and society as a whole.

Contention

Despite the general support, there are concerns among critics who argue that implementing such programs may require significant funding and resources that are not guaranteed. Additionally, discussions have surfaced regarding the potential risk of inadequate treatment leading to poor outcomes if proper guidelines and supervision are not established effectively. The balance between ensuring adequate care and managing state budgets is a point of contention highlighted in legislative discussions around SB253.

Companion Bills

No companion bills found.

Previously Filed As

PA SB691

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

PA SB962

Providing for involuntary examination and treatment of substance use disorders.

PA HB866

In public safety, providing for study of barriers to substance use disorder treatment; and imposing powers and duties on the Department of Health.

PA HB1045

Treatment for Substance Use Disorders

PA HB561

In Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PA HB1515

In Nonnarcotic Medication-assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for prior authorization, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PA SB872

In Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PA HB1650

Providing for substance use treatment and recovery support and for powers and duties of the Department of Drug and Alcohol Programs; and establishing the Lifetime Recovery from Substance Use Grant Program.

PA HB1783

Providing for substance use overdose awareness, treatment and recovery support and for powers and duties of the Department of Drug and Alcohol Programs; and establishing the Lifetime Recovery from Substance Use Grant Program.

PA AB2733

Parolee substance use disorder treatment.

Similar Bills

PA SB691

Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

PA SB872

In Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PA HB1515

In Nonnarcotic Medication-assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for prior authorization, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PA HB561

In Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

CA AB715

Workgroup review of opioid pain reliever use and abuse.

CA SB1502

Controlled substances: xylazine.

NJ A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

CA AB2783

Controlled substances: hydrocodone combination products: schedules.